Post written by Anna Tavakkoli, MD, from the University of Texas Southwestern, Dallas, Texas, USA. Endoscopic retrograde cholangiopancreatography (ERCP) is the primary therapeutic procedure for a number of pancreaticobiliary diseases. The most common adverse event associated with ERCP is post-ERCP pancreatitis (PEP). Studies estimate that PEP can occur in 10% to 15% of patients, and …
Tag: pancreatitis
Risk of post–endoscopic retrograde cholangiopancreatography pancreatitis due to placement of biliary self-expandable metal stents: a single-center retrospective study
Post written by Bashar Qumseya, MD, MPH, FASGE, from the University of Florida, Gainesville, Florida, USA. This study focuses on the risk of post-ERCP pancreatitis (PEP) in patients who receive self-expandable metal stents (SEMSs) compared with plastic biliary stents at the time of ERCP. We observed several patients who underwent PEP with seemingly no other …
Quadrant, necrosis, and infection criteria for the risk stratification of walled-off necrosis: external validation using multi-institutional data
Post written by Hideyuki Shiomi, MD, PhD, from the Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Hyogo, and Tomotaka Saito, MD, PhD, from the Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan, for the WONDERFUL study group. Our study externally validated the quadrant (an abdominal quadrant distribution), necrosis, and infection (QNI) …
Editor’s Choice: Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset
GIE Associate Editor Shivangi T. Kothari, MD, FACG, FASGE, highlights this article from the March issue: “Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset” by Samuel Han, MD, MS, et al. Post-ERCP pancreatitis (PEP) remains one of the most unpredictable, humbling, and challenging adverse events of ERCP. This study highlights …
Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset
Post written by Georgios Papachristou, MD, PhD, from the Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. This was a secondary data analysis of the stent versus indomethacin (SVI) trial, a recently completed, National Institutes of Health—funded, multicenter, randomized controlled trial including 20 centers in the United States …
Pancreatoscopy-assisted removal of Ascaris from main pancreatic duct
Post written by Vikas Sengar, MD, DM, Alok Gupta, MD, DM, and Arun Khanduri, MD, DM, from the Department of Gastroenterology, Medihelp Hospital, Kanpur, India. As gastroenterologists practicing in India, we frequently encounter patients with worms in the gut. They may be as tiny as pinworms and as huge as Taenia (tapeworms). They suck blood and food materials and sometimes block the …
Continue reading Pancreatoscopy-assisted removal of Ascaris from main pancreatic duct
Clinical predictive value of renalase in post-ERCP pancreatitis
Post written by Thiruvengadam Muniraj, MD, from the Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Post-ERCP pancreatitis (PEP) is the most common adverse event after ERCP. Despite adoption of several strategies such as rectal indomethacin, pancreatic duct stent placement, and aggressive fluid administration, incidence of PEP remains substantial. Identifying patients who are likely to develop …
Continue reading Clinical predictive value of renalase in post-ERCP pancreatitis
Gastrogastric intussusception and acute pancreatitis caused by a large pyloric gland adenoma treated with endoscopic submucosal dissection
Post written by Robert Bechara, MD, from Queen's University, Kingston Health Sciences Center, Kingston, Ontario, Canada. This is a case of a 75-year-old woman with gastrogastric intussusception and acute pancreatitis caused by a 6-cm dysplastic pyloric gland adenoma, which we treated using endoscopic submucosal dissection (ESD). The decision to showcase this video was driven by …
Precut papillotomy on a minor papilla followed by balloon papilloplasty to provide a complete pancreatic-duct drainage in tropical pancreatitis with reverse pancreas divisum
Post written by Rungsun Rerknimitr, MD, FRCP (London), FASGE, from Chulalongkorn University, Bangkok, Thailand. Our case is about a 10-year-old girl with known tropical chronic pancreatitis with mutation at the transition c.206C>T in exon 4 of the SPINK1 gene who underwent pancreatic sphincterotomy via major papilla with pancreatic stone extraction 6 months prior. The patient presented with a new episode of epigastric pain and elevation …
Visceral artery pseudoaneurysms in necrotizing pancreatitis: risk of early bleeding with lumen-apposing metal stents
Post written by Guru Trikudanathan, MD, from the Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA. Visceral artery pseudoaneurysm (PSA) after necrotizing pancreatitis (NP) arises from enzymatic degradation of the arterial wall by the pancreatic enzymes or infection, direct erosion by necrosis, or traumatic injury to small arteries during interventions resulting …
endoscopedia.com 